Description
MiCareo provides innovative tools for the analysis of rare cells. Our circulating tumor cell platform does rare cell isolation and analysis for cancer prognosis and treatment development and efficacy evaluation.
Team Members
Jiu-Lin Chen
CEO
Daniel Chiu
Co-founder, A. Bruce Montgomery Professor of Chemistry, Endowed Professor of Analytical Chemistry, and Professor of Bioengineering at the University of Washington
Perry Schiro, Co-founder
Chief Technology Officer
Hong-Jen Chang
Chairman of the Board